CY1113085T1 - Υδατοδιαλυτο σκευασμα που περιεχει ουμπικινονη για οφθαλμικη χρηση - Google Patents
Υδατοδιαλυτο σκευασμα που περιεχει ουμπικινονη για οφθαλμικη χρησηInfo
- Publication number
- CY1113085T1 CY1113085T1 CY20121100775T CY121100775T CY1113085T1 CY 1113085 T1 CY1113085 T1 CY 1113085T1 CY 20121100775 T CY20121100775 T CY 20121100775T CY 121100775 T CY121100775 T CY 121100775T CY 1113085 T1 CY1113085 T1 CY 1113085T1
- Authority
- CY
- Cyprus
- Prior art keywords
- ocyclicon
- water
- optical use
- ubiquinone
- soluble package
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Ophthalmology & Optometry (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
Abstract
Σκεύασμα για οφθαλμική χρήση, στη μορφή υδατικού διαλύματος, που περιέχει ουμπικινόνη Q10 σε συνδυασμό με βιταμίνη Ε στη μορφή του ΤΡGS (ηλεκτρικός εστέρας d-α-τοκοφερολικής πολυαιθυλενικής γλυκόλης 1000). Η τελευταία είναι ένα αποτελεσματικό αντιοξειδωτικό που όχι μόνο δρα συνεργιστικά με την ουμπικινόνη αλλά επίσης συμπεριφέρεται ως αποτελεσματικός διαλυτοποιητής για την ίδια την ουμπικινόνη, η οποία απουσία της θα ήταν εντελώς αδιάλυτη σε υδατικό περιβάλλον.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT000153A ITRM20030153A1 (it) | 2003-04-03 | 2003-04-03 | Formulazione idrosolubile contenente ubichinone per uso oftalmico. |
EP04101334A EP1464341B1 (en) | 2003-04-03 | 2004-03-31 | Ubiquinone-containing water-soluble formulation for ophthalmic use |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1113085T1 true CY1113085T1 (el) | 2016-04-13 |
Family
ID=29765745
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20121100775T CY1113085T1 (el) | 2003-04-03 | 2012-08-29 | Υδατοδιαλυτο σκευασμα που περιεχει ουμπικινονη για οφθαλμικη χρηση |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP1464341B1 (el) |
CY (1) | CY1113085T1 (el) |
DK (1) | DK1464341T3 (el) |
ES (1) | ES2385037T3 (el) |
IT (1) | ITRM20030153A1 (el) |
PL (1) | PL1464341T3 (el) |
PT (1) | PT1464341E (el) |
SI (1) | SI1464341T1 (el) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10046541A1 (de) * | 2000-09-19 | 2002-03-28 | Knoll Ag | Mechanisch stabile darreichungsformen, enthaltend Ubichinone |
CN101031284A (zh) * | 2004-09-30 | 2007-09-05 | 伊斯曼化学公司 | 使亲脂性药物增溶而无显著外排抑制作用的含有维生素e tpgs分子的药物制剂和该制剂的用途 |
FR2892936A1 (fr) * | 2005-11-10 | 2007-05-11 | Galderma Res & Dev | Composition pharmaceutique ou cosmetique, et procede de solubilisation mixte pour preparer la composition. |
CN101677588A (zh) * | 2007-02-01 | 2010-03-24 | 加拿大国家研究委员会 | 亲脂性生物活性分子制剂 |
WO2008101344A1 (en) * | 2007-02-22 | 2008-08-28 | Peter Tomlinson | Soluble bioactive lipophilic compounds compositions |
GB0905348D0 (en) * | 2009-03-27 | 2009-05-13 | Ucl Business Plc | Carrier |
GB0724772D0 (en) * | 2007-12-19 | 2008-01-30 | Ucl Business Plc | Carrier |
US9481856B2 (en) | 2008-06-09 | 2016-11-01 | Bausch & Lomb Incorporated | Pharmaceutical formulations comprising stabilized polysaccharides and source of hydrogen peroxide |
RU2445079C2 (ru) * | 2010-06-02 | 2012-03-20 | Общество С Ограниченной Ответственностью "Акцент" | Композиция на основе 6-декапренил-2,3-диметокси-5-метил-1,4-бензохинона и способ ее получения |
ITRM20120331A1 (it) | 2012-07-12 | 2014-01-13 | Guidotti & C Spa Labor | Composizioni pediatriche orali liquide contenenti nepadutant. |
EP3673896B9 (en) * | 2018-12-28 | 2022-05-18 | Dr. Rolf Lambert Pharma-Consulting GmbH | Liposomial eye drops solution and uses thereof for the treatment of dry eye syndrome |
DE102021212692A1 (de) | 2021-11-11 | 2023-05-11 | Ursapharm Arzneimittel Gmbh | Selbstemulgierende öl-in wasser-mikro- oder nanoemulsion so-wie emulgierende zusammensetzung |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5558876A (en) * | 1995-03-29 | 1996-09-24 | Alcon Laboratories, Inc. | Topical ophthalmic acidic drug formulations |
IT1307281B1 (it) | 1999-11-25 | 2001-10-30 | Simonelli Giuseppe | Uso di ubichinone q10 per il trattamento locale e la prevenzione dipatalogie oftalmologiche secondarie alla terapia fotorefrattiva, |
AUPQ761100A0 (en) | 2000-05-18 | 2000-06-08 | Australian Rural Group Limited | Lipophilic medicament |
ITRM20010755A1 (it) * | 2001-12-20 | 2003-06-20 | Simonelli Giuseppe | Uso del chinone q10 per il trattamento delle malattie oculari. |
-
2003
- 2003-04-03 IT IT000153A patent/ITRM20030153A1/it unknown
-
2004
- 2004-03-31 EP EP04101334A patent/EP1464341B1/en not_active Expired - Lifetime
- 2004-03-31 PT PT04101334T patent/PT1464341E/pt unknown
- 2004-03-31 ES ES04101334T patent/ES2385037T3/es not_active Expired - Lifetime
- 2004-03-31 PL PL04101334T patent/PL1464341T3/pl unknown
- 2004-03-31 DK DK04101334.3T patent/DK1464341T3/da active
- 2004-03-31 SI SI200431905T patent/SI1464341T1/sl unknown
-
2012
- 2012-08-29 CY CY20121100775T patent/CY1113085T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
DK1464341T3 (da) | 2012-07-09 |
SI1464341T1 (sl) | 2012-09-28 |
EP1464341A1 (en) | 2004-10-06 |
EP1464341B1 (en) | 2012-05-30 |
PL1464341T3 (pl) | 2012-10-31 |
ITRM20030153A0 (it) | 2003-04-03 |
ITRM20030153A1 (it) | 2004-10-04 |
PT1464341E (pt) | 2012-07-13 |
ES2385037T3 (es) | 2012-07-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1113085T1 (el) | Υδατοδιαλυτο σκευασμα που περιεχει ουμπικινονη για οφθαλμικη χρηση | |
CY1124262T1 (el) | Σκευασματα βενδαμουστινης | |
UY26496A1 (es) | Composiciones farmacéuticas que proporcionan concentraciones potenciadas de fármaco | |
BRPI0418330A (pt) | composições sólidas de drogas de solubilidade baixa e poloxámeros | |
AR029737A1 (es) | Concentrados de anticongelantes a base de amidas y composiciones refrigerantes que los comprenden, para la proteccion del magnesio y aleaciones de magnesio | |
HN2002000275A (es) | Derivados de 1,8 naftiridina y su uso para el tratamiento de diabetes y trastornos relacionados | |
ECSP045082A (es) | Formulación granular | |
CY1119038T1 (el) | Φαρμακευτικο εναιωρημα | |
ECSP055853A (es) | Nuevos derivados de fluoroglicosidos heterociclicos, productos farmaceuticos que contienen dichos compuestos, y el uso de los mismos | |
CR20140541A (es) | Formulaciones farmacéuticas tópicas no acuosas | |
CY1113988T1 (el) | Συνδυαστικο σκευασμα για τη βελτιωση της ποιοτητας του σπερματος | |
HN2002000300A (es) | Nuevos derivados de piperazina | |
BR112015003655A2 (pt) | composto; uso de um composto; e composição farmacêutica | |
CO2019007888A2 (es) | Inhibidores selectivos de jak1 | |
HN2003000183A (es) | Difenilazetidinonas sustituidas en anillo procedimiento para su preparacion, medicamentos que comprenden estos compuestos y su uso. | |
UY38809A (es) | Derivados de 3,6-diamino-piridazin-3ilo, composiciones farmacéuticas que los contienen y sus usos como agentes proapoptóticos | |
UY28536A1 (es) | Derivados de bencimidazol, composiciones que los contienen, preparacion y usos de los mismos. | |
CY1110213T1 (el) | Παραγωγα αζολοπυριδιν-2-ονης ως αναστολεις λιπασων και φωσφολιπασων | |
CR11584A (es) | Derivados de oxindol sustituidos y uso de los mismos para el tratamiento de enfermedades dependientes de la vasopresina | |
FR3014688B1 (fr) | Composition a base d'acide gras polyinsature et de carotenoide destinee a une administration par voie orale pour ameliorer la qualite de la chevelure | |
DE60318309D1 (de) | Polyarylenetherzusammensetzungen mit verringerter vergilbung und hoher lichtdurchlässigkeit und daraus hergestellte gegenstände | |
ES2180319T3 (es) | Utilizacion de derivados de metilenbisoxazolidina y composiciones de los mismos. | |
SV1999000204A (es) | Derivados de indol ref. pcs10311aksr/bb | |
UY27753A1 (es) | Formulación farmacéutica que comprende melatonina. | |
MA50116A1 (fr) | Agent d'absorption transdermique comprenant du donépézil pour le traitement de la démence |